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Measurement of quantum yield
The relative quantum yield of FeSe QDs was 40% when rhodamine B (RhB) was chosen as the standard. The quantum yield was calculated using the following equation
In the equation, R and S represent RhB and the sample, respectively. Q is the quantum yield, I is the integral area of emission spectrum, A is the absorbance intensity at the excitation wavelength and N is the refractive index of the solvent. Here, RhB was used as the standard sample and dissolved in ethanol with a quantum yield of 95%, and samples were dissolved in deionized water.
Cell Culture
The AGS human gastric adenocarcinoma, MG-63 human osteosarcoma, and NCI-H460 human lung carcinoma cell lines were purchased from the Korean Cell Line Bank (Seoul, Korea). AGS and NCI-H460 cells were cultured in Roswell Park Memorial Institute (RPMI) medium 1640 supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT), penicillin (100 IU mL -1 ), and streptomycin (100 µg mL -1 ). MG-63 cells were cultured in Eagle's Minimum Essential Medium containing 10% FBS, penicillin (100 IU mL -1 ), and streptomycin (100 µg mL -1 ). All cells were maintained in a humidified incubator containing 5% CO 2 at 37 °C. To evaluate the cell viability, an aqueous solution of FeSe QDs was added to each cell line at different final concentrations (25, 50, and 70 μg mL -1 ) dissolved in distilled water every other day (3, 5, and 7 days).
Flow Cytometry
To measure cell viability, the percentage of live cells was evaluated using a Muse™ Cell Analyzer (PB4455ENEU; Millipore Co., Billerica, MA). The prepared cells were suspended at a final cell concentrations 1 × 10 5 cells mL -1 . The suspended cells (100 μL) were stained with Muse™ Annexin V & Dead Cell Reagent (MCH100105; Millipore Co., Darmstadt, Germany) for 20 min at 25°C, after which flow cytometry was carried out to determine cell viability.
Fluorescein Diacetate Assay
To observe the morphological features of live cells, fluorescein diacetate (FDA, F7378; Sigma-Aldrich, St. Louis, MO) staining was performed. FDA is a non-fluorescent, hydrophobic substance that can penetrate the cell membrane and is metabolically hydrolyzed by cytoplasmic lipase and emits green fluorescence.(43) The medium was removed and the cells were washed with PBS and treated with an FDA stock solution (5 mg of FDA per mL of acetone) diluted in PBS (1:100). After 15 min of incubation at 37°C, cell morphology was observed using a fluorescence microscopy (Eclipse TS100, Nikon, Japan) at an excitation wavelength 488 nm. (Comments) Three human cancer cell lines (AGS, MG63, NCI-H460) were chosen to evaluate the biocompatibility of FeSe QDs based on the fluorescein diacetate assay because it is possible for diverse cells of each organ to exhibit different responses to the QDs. The fluorescence microscopic images of cells imply that the FeSe QDs possess superior biocompatible nature regardless of its concentration. The QDs induced similar proliferation as that of non-treated control cells for up to seven days. More details are described in the main manuscript. Fig. S4 . Tumor cell targeting specificity of anti-HER2-QDs. Two-photon and threephoton fluorescence images of HER2-non-expressed (MCF7) and HER2-overexpressed (HER2) MCF7 cells stained with anti-HER2-QDs at 2, 20, and 100 μg mL -1 (λ ex : 800 nm for two-photon and 1080 nm for three-photon fluorescence).
(Comment) Figure S4 shows that without PEGylation, both the physically adsorbed and covalently bound anti-HER2-QDs did not have distinct selectivity for the HER2-overexpressed cells against HER2-non-expressed MCF7 cells, demonstrating the non-specific internalization behavior of anti-HER2-QDs at concentrations of 20 and 100 μg/ mL -1 in the cell cytoplasm. In other words, anti-HER2-QDs were internalized in the normal cells as well as HER2-overexpressed cells depending on their concentration without selectivity. (Comment) Figure S5 shows the evaluation of the non-specific uptake and selectivity of anti-HER2-PEG-QDs for human breast cancer cell targeting. FeSe QDs were encapsulated with PEG before conjugation with HER2 antibodies to form anti-HER2-PEG-QDs to avoid nonspecific internalization. Both HER2-non-expressed and HER2-overexpressed MCF7 cells were stained with anti-HER2-PEG-QDs and PEG-QDs that were not conjugated with HER2 antibodies. The nuclei of the cells were stained with propidium iodide. Figure S5 shows that all samples exhibited red fluorescence signals from propidium iodide in the nuclei and only HER2-overexpressed MCF7 cells stained with anti-HER2-PEG-QDs emitted cyan fluorescence. Neither cellular uptake nor cell surface binding was observed in the control samples, indicating that anti-HER2-PEG-QDs specifically targeted HER2 receptors. Figure S6 . The anti-HER2-PEG-QDs were physiologically stable and maintained optical properties for seven days in serum and in various buffer solutions ( fig. S6) , with <1% hemolysis rate at a QD concentration of 100 μg/ mL -1 (fig. S7 ). Hemocompatibility blood samples were gathered from the heart and caudal vena cava of mice. After centrifugation at 1500 rpm for 5 min, the red blood cells were resuspended in PBS with a final concentration of 2%. The cells were then incubated with FeSe QDs at different concentrations at 37°C for 2 h. The absorption was determined at 560 nm using a microplate reader (Tecan Group Ltd., Männedorf, Switzerland). Triton X-100 (1%) was utilized as a positive control. The percentage of hemolysis was calculated as follows: the hemolysis % = [(sample absorbance − negative control absorbance) / (positive control absorbancenegative control absorbance)] × 100%. Figures S8, S9 . The FeSe QDs, which were found around HER2-overexpressed MCF7 cells, were identified in cyan. The color replacement method was applied, whereby cyan was extracted using the color threshold method and separated from the original data. The intensity of the extracted cyan FeSe QDs was replaced by magenta and combined with the original data. This color replacement method was applied to the images from both HER2overexpressed and normal MCF7 cells, and the final images showed better contrast and distinction ( Fig. 3i and 3j) . Moreover, the color threshold method was used to remove the second harmonic generation (SHG) signal of collagen caused by a laser with a wavelength of 800 nm.
Fig. S8. In vivo two-photon microscopic images before and after SHG signal removal.
Original in vivo two-photon microscopic images and images after removal of SHG signals by color threshold technique before and after injecting anti-HER2-QDs. Scale bar: 20 μm. 
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Movie S1. In vitro two-photon microscopic images of HER2-overexpressed MCF7 cells (positive control) after treatment with anti-HER2-PEG-QDs (20 μg ml -1 ). Cell nucleus: Propidium iodide (red fluorescence) (λ ex = 500 nm) Cell membrane: anti-HER2-PEG-QDs (λ ex = 800 nm) * Laser power: 40 mW at focal plane Movie S2. In vitro two-photon microscopic images of MCF7 cells (negative control) after treatment with anti-HER2-PEG-QDs (20 μg ml -1 ). The acquisition parameters, color channels, and scaling were the same as those of movie S1 Movie S3. In vivo two-photon microscopic images (Z-scan) of cancer part were obtained 30 min after intravenous tail vein injection of anti-HER2-PEG-QDs by moving the excitation focal plane from 450 to 525 μm from the skin in 5-μm steps (λ ex = 800 nm, power = 100 mW). The SHG signal from collagen was high in the layer between 450 μm and 470 μm (blue channel), and higher signal of QDs was detected in the area between 470 μm and 500 μm from the surface (blue and green channel). * Two-photon excitation wavelength: 800 nm. * Laser power: 100 mW at focal plane. * Imaging direction: from a depth of 450 μm to 525 μm (relative to skin surface) in the zdirection, 5-μm steps. * Scale bar: 20 μm.
